• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Cardiovascular-kidney-metabolic health reflects the interplay among metabolic risk factors,
chronic kidney disease, and the cardiovascular system and has profound impacts on …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Accompanying the aging of populations worldwide, and increased survival with chronic
diseases, the incidence and prevalence of atrial fibrillation (AF) are rising, justifying the term …

Background: Coronavirus disease 2019 (COVID-19) has led to over 1 million deaths
worldwide and has been associated with cardiac complications including cardiac …

Atrial fibrillation (AF) is the most common arrhythmia (estimated lifetime risk, 22%–26%). The
aim of this article is to review the clinical epidemiological features of AF and to relate them to …

Atrial fibrillation (AF) is a major public health burden worldwide, and its prevalence is set to
increase owing to widespread population ageing, especially in rapidly developing countries …

Background Diabetes and elevated blood glucose have been associated with increased risk
of atrial fibrillation in a number of epidemiological studies, however, the findings have not …

BACKGROUND: Atrial fibrillation is associated with substantial mortality and morbidity from
stroke and thromboembolism. Despite an efficacious oral anticoagulation therapy (warfarin) …

Atrial fibrillation (AF) is 1 of the most clinically diagnosed cardiac disturbances but little is
known about its risk factors. Previous epidemiologic studies have reported on the …